FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Bausch Health Companies Omeprazole and Sodium Bicarbonate For Oral Recall

Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contai…

Bausch Health Companies, Inc. · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Mar 6, 2024
Recall ID
D-0355-2024
Check your lot numberHow we source this data

Summary

Bausch Health Companies recalled Omeprazole and Sodium Bicarbonate For Oral starting Feb 2, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0355-2024 on Mar 6, 2024. Reason: Subpotent Drug: Out of specification for assay. Status: Completed.

Why it was recalled

Subpotent Drug: Out of specification for assay

Product description

Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807, NDC 68682-991-30.

Lot numbers, UPCs & expiration codes

Lot #0013R; Exp. 01/2026

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0355-2024
Classification
Class II
Status
Completed
Recall initiated
Feb 2, 2024
FDA report date
Mar 6, 2024
Quantity
3,600 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Bausch Health Companies, Inc.

Original FDA data

Every field from FDA enforcement report D-0355-2024, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Completed
Country
United States
Event ID
93911
Address
400 Somerset Corporate Blvd
Code information
Lot #0013R; Exp. 01/2026
Postal code
08807-2867
Report date
Mar 6, 2024
Product type
Drugs
Recall number
D-0355-2024
Classification
Class II
Recalling firm
Bausch Health Companies, Inc.
Product quantity
3,600 cartons
Reason for recall
Subpotent Drug: Out of specification for assay
Voluntary / mandated
Voluntary: Firm initiated
Product description
Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807, NDC 68682-991-30.
Distribution pattern
Nationwide
Recall initiation date
Feb 2, 2024
Initial firm notification
Letter
Center classification date
Feb 28, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0355-2024, published Mar 6, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls